AstraZeneca | AZN - Market Capitalization


AstraZeneca reported $184.19B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 435.86B 8.73B Aug/2026
Alcon AG USD 37.06B 5.98B Mar/2026
Almirall EUR 2.76B 472.53M Dec/2025
Amgen USD 209.65B 14.21B Aug/2026
argenx SE USD 57.63B 13.25B Jun/2026
AstraZeneca USD 178.16B 111.83B Aug/2026
Autolus Therapeutics Ltd USD 367.28M 0 Aug/2026
Bayer EUR 49.51B 10.82B Aug/2026
Biogen USD 31.9B 5B Jun/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Eli Lilly USD 1.11T 18.32B Aug/2026
Fresenius EUR 26.29B 3.78B Aug/2026
Fresenius Medical Care EUR 11.32B 642.58M Mar/2026
Genmab DKK 20.48B 1.02B Dec/2025
Gilead Sciences USD 168.68B 11.82B Aug/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
GRIFOLS EUR 4.25B 1.16B Aug/2026
Haleon GBP 33.16B 2.53B Aug/2026
Hikma Pharmaceutical USD 3.49B 1.14B Aug/2026
Lakefront Biotherapeutics EUR 1.73B 119.93M Mar/2026
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 63.22B 16.43B Aug/2026
Merck USD 324.18B 6.81B Aug/2026
Novartis USD 240.59B 67.17B Jun/2026
Orion EUR 10.15B 316M Jun/2026
Pfizer USD 143.89B 5.44B Aug/2026
Philips EUR 23.09B 615.44M Jun/2026
Recordati EUR 10.65B 209.88M Aug/2026
Regeneron Pharmaceuticals USD 65.37B 16.31B Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 91.15B 9.12B Jun/2026
UCB EUR 46.41B 13.94B Dec/2025